100 participants
Adjuvant Immune Checkpoint Inhibitor Versus Observation After Neoadjuvant Immunochemotherapy and Surgery in High-Risk NSCLC
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-05
- Start Date:
- 2025-01-10
- Completion:
- 2027-12-30
Conditions
- Non-Small Cell Lung Cancer
- Adjuvant Therapy
- Immune Checkpoint Inhibitors
Interventions
- DRUG
No Results Yet